AI assistant
Sending…
RIGEL PHARMACEUTICALS INC — Director's Dealing 2016
May 13, 2016
32801_dirs_2016-05-12_664fafb5-6cf6-4a7e-b039-80379d558040.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2016-05-11
Reporting Person: Goodwin Bradford S (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-11 | Stock Option (Right to Buy) | $2.40 | A | 40000 | Acquired | 2026-05-11 | Common Stock (40000) | Direct |
Footnotes
F1: The shares vest monthly over twelve (12) months from the date of grant.
More from RIGEL PHARMACEUTICALS INC
Board/Management Information
2026
Jul 1
Regulatory Filings
2026
Jun 17
Call Transcript
2026
Jun 3
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Call Transcript
2026
May 19
Call Transcript
2026
May 12
Regulatory Filings
2026
May 12
Call Transcript
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27